Cleared Traditional

K941923 - STERILE TREATMENT ELECTRODE

K941923 is an FDA 510(k) clearance for STERILE TREATMENT ELECTRODE, manufactured by Staodyne, Inc.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 408-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1995
Decision
408d
Days
Class 2
Risk

K941923 is an FDA 510(k) clearance for the STERILE TREATMENT ELECTRODE. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Staodyne, Inc. (Longmont, US). The FDA issued a Cleared decision on June 2, 1995 after a review of 408 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Neurology submissions.

FDA 510(k) Submission Details - K941923

510(k) Number K941923 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 20, 1994
Decision Date June 02, 1995
Days to Decision 408 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
259d slower than avg
Panel avg: 149d · This submission: 408d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 605
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K941923.
STIMULATOR, NERVE, TRANSCUTANEOUS, (PAIN RELIEF) 84-GZJ
K940600 · Progressive Concepts, Inc. · Sep 1995
PGS123 AND HVS-123
K946299 · Skylark Device Co., Ltd. · Jun 1995
THE SIGNATURE SERIES, M IV
K933197 · Progressive Electrical Therapeutics · Jun 1995
TRANSAMERICAN CLASSIC TENS
K944280 · Transamerica Biomedical, Inc. · May 1995
GUARDIAN DISPOSABLE TENS AND TENS/NMES ELECTRODES
K945676 · Selectivemed Components, Inc. · Jan 1995
MEDI-STIM, MODIFICATION
K933237 · Mid-Canada Medical · Sep 1994